In Re UnitedHealth Group Inc. Shareholder Derivative Litigation

754 N.W.2d 544, 2008 WL 3467254
CourtSupreme Court of Minnesota
DecidedAugust 14, 2008
DocketA08-114
StatusPublished
Cited by41 cases

This text of 754 N.W.2d 544 (In Re UnitedHealth Group Inc. Shareholder Derivative Litigation) is published on Counsel Stack Legal Research, covering Supreme Court of Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re UnitedHealth Group Inc. Shareholder Derivative Litigation, 754 N.W.2d 544, 2008 WL 3467254 (Mich. 2008).

Opinions

OPINION

ANDERSON, G. BARRY, Justice.

This case arises from a certified question from the United States District Court for the District of Minnesota regarding the extent to which a court, in deciding whether to approve a proposed settlement of a shareholder derivative action, must defer to the decision of a special litigation committee “SLC” that the derivative action should be settled on specific terms.

In 2006 the Wall Street Journal reported that executives at various U.S. corporations received stock options on dates that coincided with a low price (or, in some cases, the lowest price for a given time frame) and that those options appeared to have been backdated.1 See Charles Fo-[548]*548relie & James Bandler, The Perfect Payday, Wall St. J., Mar. 18, 2006, at Al. Among the corporations discussed in the article was UnitedHealth Group, Inc. (“UnitedHealth”), see id., a Minnesota corporation with its principal executive offices in Minnetonka. The article noted that Dr. William McGuire, CEO and chairman of the board of UnitedHealth, received Uni-tedHealth stock options that might have been backdated. Id. McGuire subsequently resigned from his position at United-Health.

Shortly after the publication of the Wall Street Journal article, a number of actions were brought against McGuire and other UnitedHealth executives, including (1) federal shareholder derivative litigation, (2) federal securities class actions under the Private Securities Litigation Reform Act (“PSLRA litigation”), and (3) state derivative suits under Minnesota law. The state derivative suits were brought in Minnesota district court, whereas the federal derivative litigation and PSLRA litigation were brought in the United States District Court for the District of Minnesota. The Securities Exchange Commission brought its own action against McGuire; the parties reached a settlement in which McGuire agreed to return $400 million to UnitedHealth and pay a $7 million civil fine. In settling the SEC action, McGuire agreed not to “make or permit to be made any public statement denying, directly or indirectly, any allegation in the [SEC] complaint or creating the impression that the complaint is without factual basis.”

On July 19, 2006, UnitedHealth’s board passed a resolution creating a two-member SLC under Minn.Stat. § 302A.241, subd. 1 (2006).2 Both members of the SLC are former justices of this court. The board resolution conferred on the SLC “complete power and authority to investigate [the derivative claims] and analyze the legal rights or remedies of the Company and determine whether those rights or remedies should be pursued.” In the resolution, the board also retained the ability to expand the size of the SLC as it deemed appropriate. On November 29, 2006, the federal district court issued a preliminary injunction preventing McGuire from exercising any UnitedHealth stock options without court approval. The injunction was set to expire after the SLC issued its report.

Following an extensive investigation, the SLC issued its report on December 6, 2007. In the report, the SLC set forth the legal standards and defenses applicable to each derivative claim. Citing the “ongoing federal securities fraud actions involving similar allegations,” however, the SLC declined to provide any detailed factual bases for its conclusions. In the end, the SLC determined that a number of the claims “may have merit” and recommended settlement of the claims against McGuire and settlement or dismissal of the claims against the other named defendants. Un[549]*549der the terms of the proposed settlement, McGuire would relinquish approximately $320 million in UnitedHealth stock options, surrender his rights to his UnitedHealth retirement plan and executive savings plan, and relinquish any claim he might have had to post-employment benefits. The total economic value McGuire would relinquish under the settlement amounted to approximately $420 million.

On the basis of the recommended settlement with McGuire, the federal derivative plaintiffs joined with the defendants to request the lifting of the preliminary injunction on McGuire’s stock options in excess of the proposed settlement. In re United-Health Group Inc. S’holder Derivative Litig., Nos. 06-CV-1216, 06-CV-1691, 2007 WL 4571127, at *2 (D.Minn. Dec. 26, 2007). But one party, the California Public Employees’ Retirement System (“CalPERS”), requested that the injunction be maintained, fearing that “release of the funds will jeopardize its ability to collect a judgment, should it prevail in the PSLRA litigation.” Id.

Applying federal precedent regarding the termination of preliminary injunctions, the federal district court considered the factors set forth in Dataphase Systems, Inc. v. CL Systems, Inc., 640 F.2d 109, 113 (8th Cir.1981).3 UnitedHealth, 2007 WL 4571127, at *2. In its evaluation of Cal-PERS’s chance of success on the merits, the court noted a “significant probability” of success, based in part on what the court construed as McGuire’s admission of wrongdoing to the SEC. Id. at *5-6. Nevertheless, the court believed that “the ultimate question” was whether the Uni-tedHealth board could in good conscience release approximately $800 million in compensation to an individual who could not deny substantial malfeasance in his capacity with the company. Id. at *6. The court noted that although the SLC had “apparently made a business judgment favoring settling the Board’s and UHG’s possible claims,” the SLC’s “lack of any findings leaves no tracks showing why or how its business judgment can be considered reasonable.” Id. The court stated that if Minnesota law permitted a more searching analysis, then “there may be a ground upon which to preserve additional assets pending approval of the settlement.” Id.

Declining to speculate on the scope of Minnesota law, the district court chose to certify to this court the following question: “Does Minnesota’s business judgment rule foreclose a court from a) examining the reasonableness of, or b) rejecting on the merits, a settlement of a derivative action proposed by a Special Litigation Committee duly constituted under Minnesota Statutes § 302A.241 subd. 1?” UnitedHealth, 2007 WL 4571127, at *8. We accepted the certified question, which we reformulated to read as follows:

To what extent does the business judgment rule as recognized in Minnesota law require a court, in deciding whether to approve a proposed settlement of a shareholder derivative action, to defer to the decision of a Special Litigation Committee duly constituted under MinmStat. § 302A.241, subd. 1 (2006), that the derivative action should be settled on specific terms?

I.

Under Minn.Stat. § 480.065, subd. 3 (2006), we “may answer a question of law certified ... by a court of the United [550]*550States ... if the answer may be determinative of an issue in pending litigation in the certifying court and there is no controlling appellate decision, constitutional provision, or statute of this state.” A certified question is a question of law that we review de novo. Clark v. Lindquist, 683 N.W.2d 784, 785 (Minn.2004).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Walsh v. Buchholz
D. Minnesota, 2023
IN RE: DISH NETWORK DERIVATIVE LITIG. C/W 69012
2017 NV 61 (Nevada Supreme Court, 2017)
In re Medtronic, Inc. Shareholder Litigation
900 N.W.2d 401 (Supreme Court of Minnesota, 2017)
Blum v. Thompson
901 N.W.2d 203 (Court of Appeals of Minnesota, 2017)
Charlotte Kokocinski v. Arthur D. Collins, Jr.
850 F.3d 354 (Eighth Circuit, 2017)
Kelly v. BMO Harris Bank N.A. (In re Peters Co.)
565 B.R. 154 (D. Minnesota, 2017)
State of Minnesota v. Kristyn Nicole Schouweiler
887 N.W.2d 22 (Supreme Court of Minnesota, 2016)
James L. Mandel v. Multiband Corporation
Court of Appeals of Minnesota, 2016
Wayzata Nissan, LLC v. Nissan North America, Inc., Stephen J. McDaniels
875 N.W.2d 279 (Supreme Court of Minnesota, 2016)
328 Barry Avenue, LLC v. Nolan Properties Group, LLC
871 N.W.2d 745 (Supreme Court of Minnesota, 2015)
In re Medtronic, Inc. Derivative Litigation
68 F. Supp. 3d 1054 (D. Minnesota, 2014)
in Re Helix Energy Solutions Group, Inc.
440 S.W.3d 167 (Court of Appeals of Texas, 2013)
Boland v. Boland
31 A.3d 529 (Court of Appeals of Maryland, 2011)
Day v. Stascavage
251 P.3d 1225 (Colorado Court of Appeals, 2010)
J.E.B. v. Danks
785 N.W.2d 741 (Supreme Court of Minnesota, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
754 N.W.2d 544, 2008 WL 3467254, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-unitedhealth-group-inc-shareholder-derivative-litigation-minn-2008.